Advertisement

Index by author

September 01, 2003; Volume 31,Issue 9

B

  1. Bajpai, Manoj

    1. ONLY TRUNCATED, NOT COMPLETE CYTOCHROME P450 2D6 RNA TRANSCRIPT AND NO DETECTABLE ENZYME ACTIVITY ARE EXPRESSED IN HUMAN LYMPHOCYTES
      Lisa A. McConnachie, Brian Phillips, Manoj Bajpai, Danny D. Shen and Rodney J. Y. Ho
      Drug Metabolism and Disposition September 2003, 31 (9) 1103-1107; DOI: https://doi.org/10.1124/dmd.31.9.1103

  2. Bedard, Leanne L.

    1. BIOTRANSFORMATION OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE (NNK) IN PERIPHERAL HUMAN LUNG MICROSOMES
      Graeme B. J. Smith, John R. Bend, Leanne L. Bedard, Ken R. Reid, Dimitri Petsikas and Thomas E. Massey
      Drug Metabolism and Disposition September 2003, 31 (9) 1134-1141; DOI: https://doi.org/10.1124/dmd.31.9.1134

  3. Bend, John R.

    1. BIOTRANSFORMATION OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE (NNK) IN PERIPHERAL HUMAN LUNG MICROSOMES
      Graeme B. J. Smith, John R. Bend, Leanne L. Bedard, Ken R. Reid, Dimitri Petsikas and Thomas E. Massey
      Drug Metabolism and Disposition September 2003, 31 (9) 1134-1141; DOI: https://doi.org/10.1124/dmd.31.9.1134

  4. Benedek, Irma H.

    1. CONCURRENT INDUCTION AND MECHANISM-BASED INACTIVATION OF CYP3A4 BY AN l-VALINAMIDE DERIVATIVE
      Gang Luo, Jianrong Lin, William D. Fiske, Renke Dai, Tian J. Yang, Sean Kim, Michael Sinz, Edward LeCluyse, Eric Solon, James M. Brennan, Irma H. Benedek, Summer Jolley, Darryl Gilbert, Lifei Wang, Frank W. Lee and Liang-Shang Gan
      Drug Metabolism and Disposition September 2003, 31 (9) 1170-1175; DOI: https://doi.org/10.1124/dmd.31.9.1170

  5. Berbaum, Jennifer

    1. GENERATION AND VALIDATION OF RAPID COMPUTATIONAL FILTERS FOR CYP2D6 AND CYP3A4
      Sean Ekins, Jennifer Berbaum and Richard K. Harrison
      Drug Metabolism and Disposition September 2003, 31 (9) 1077-1080; DOI: https://doi.org/10.1124/dmd.31.9.1077

  6. Boobis, Alan R.

    1. COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS
      Jarmo S. Salonen, Leena Nyman, Alan R. Boobis, Robert J. Edwards, Patricia Watts, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria-José Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Andre Guillouzo, Laurent Corcos, Peter S. Goldfarb, David F.V. Lewis, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition September 2003, 31 (9) 1093-1102; DOI: https://doi.org/10.1124/dmd.31.9.1093

  7. Brennan, James M.

    1. CONCURRENT INDUCTION AND MECHANISM-BASED INACTIVATION OF CYP3A4 BY AN l-VALINAMIDE DERIVATIVE
      Gang Luo, Jianrong Lin, William D. Fiske, Renke Dai, Tian J. Yang, Sean Kim, Michael Sinz, Edward LeCluyse, Eric Solon, James M. Brennan, Irma H. Benedek, Summer Jolley, Darryl Gilbert, Lifei Wang, Frank W. Lee and Liang-Shang Gan
      Drug Metabolism and Disposition September 2003, 31 (9) 1170-1175; DOI: https://doi.org/10.1124/dmd.31.9.1170

  8. Burchell, Brian

    1. CONJUGATION OF CATECHOLS BY RECOMBINANT HUMAN SULFOTRANSFERASES, UDP-GLUCURONOSYLTRANSFERASES, AND SOLUBLE CATECHOL O-METHYLTRANSFERASE: STRUCTURE-CONJUGATION RELATIONSHIPS AND PREDICTIVE MODELS
      Jyrki Taskinen, Brian T. Ethell, Pia Pihlavisto, Alan M. Hood, Brian Burchell and Michael W. H. Coughtrie
      Drug Metabolism and Disposition September 2003, 31 (9) 1187-1197; DOI: https://doi.org/10.1124/dmd.31.9.1187

C

  1. Caggana, Michele

    1. SINGLE NUCLEOTIDE POLYMORPHISMS OF THE HUMAN CYP2A13 GENE: EVIDENCE FOR A NULL ALLELE
      Xiuling Zhang, Ying Chen, Yiqin Liu, Xiang Ren, Qing-Yu Zhang, Michele Caggana and Xinxin Ding
      Drug Metabolism and Disposition September 2003, 31 (9) 1081-1085; DOI: https://doi.org/10.1124/dmd.31.9.1081

  2. Castell, José V.

    1. COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS
      Jarmo S. Salonen, Leena Nyman, Alan R. Boobis, Robert J. Edwards, Patricia Watts, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria-José Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Andre Guillouzo, Laurent Corcos, Peter S. Goldfarb, David F.V. Lewis, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition September 2003, 31 (9) 1093-1102; DOI: https://doi.org/10.1124/dmd.31.9.1093

  3. Charman, William N.

    1. APPLICATION OF COMPARTMENTAL MODELING TO AN EXAMINATION OF IN VITRO INTESTINAL PERMEABILITY DATA: ASSESSING THE IMPACT OF TISSUE UPTAKE, P-GLYCOPROTEIN, AND CYP3A
      Brendan M. Johnson, William N. Charman and Christopher J. H. Porter
      Drug Metabolism and Disposition September 2003, 31 (9) 1151-1160; DOI: https://doi.org/10.1124/dmd.31.9.1151

  4. Chen, Ying

    1. SINGLE NUCLEOTIDE POLYMORPHISMS OF THE HUMAN CYP2A13 GENE: EVIDENCE FOR A NULL ALLELE
      Xiuling Zhang, Ying Chen, Yiqin Liu, Xiang Ren, Qing-Yu Zhang, Michele Caggana and Xinxin Ding
      Drug Metabolism and Disposition September 2003, 31 (9) 1081-1085; DOI: https://doi.org/10.1124/dmd.31.9.1081

  5. Cherrington, N. J.

    1. INDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 IN RAT LIVER IS ASSOCIATED WITH ALTERED VECTORIAL EXCRETION OF ACETAMINOPHEN METABOLITES
      A. L. Slitt, N. J. Cherrington, J. M. Maher and C. D. Klaassen
      Drug Metabolism and Disposition September 2003, 31 (9) 1176-1186; DOI: https://doi.org/10.1124/dmd.31.9.1176

  6. Clarke, Stephen E.

    1. MULTISITE KINETIC ANALYSIS OF INTERACTIONS BETWEEN PROTOTYPICAL CYP3A4 SUBGROUP SUBSTRATES: MIDAZOLAM, TESTOSTERONE, AND NIFEDIPINE
      Aleksandra Galetin, Stephen E. Clarke and J. Brian Houston
      Drug Metabolism and Disposition September 2003, 31 (9) 1108-1116; DOI: https://doi.org/10.1124/dmd.31.9.1108

  7. Corcos, Laurent

    1. COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS
      Jarmo S. Salonen, Leena Nyman, Alan R. Boobis, Robert J. Edwards, Patricia Watts, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria-José Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Andre Guillouzo, Laurent Corcos, Peter S. Goldfarb, David F.V. Lewis, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition September 2003, 31 (9) 1093-1102; DOI: https://doi.org/10.1124/dmd.31.9.1093

  8. Coughtrie, Michael W. H.

    1. CONJUGATION OF CATECHOLS BY RECOMBINANT HUMAN SULFOTRANSFERASES, UDP-GLUCURONOSYLTRANSFERASES, AND SOLUBLE CATECHOL O-METHYLTRANSFERASE: STRUCTURE-CONJUGATION RELATIONSHIPS AND PREDICTIVE MODELS
      Jyrki Taskinen, Brian T. Ethell, Pia Pihlavisto, Alan M. Hood, Brian Burchell and Michael W. H. Coughtrie
      Drug Metabolism and Disposition September 2003, 31 (9) 1187-1197; DOI: https://doi.org/10.1124/dmd.31.9.1187

  9. Court, Michael H.

    1. EVALUATION OF 3′-AZIDO-3′-DEOXYTHYMIDINE, MORPHINE, AND CODEINE AS PROBE SUBSTRATES FOR UDP-GLUCURONOSYLTRANSFERASE 2B7 (UGT2B7) IN HUMAN LIVER MICROSOMES: SPECIFICITY AND INFLUENCE OF THE UGT2B7*2 POLYMORPHISM
      Michael H. Court, Soundarajan Krishnaswamy, Qin Hao, Su X. Duan, Christopher J. Patten, Lisa L. von Moltke and David J. Greenblatt
      Drug Metabolism and Disposition September 2003, 31 (9) 1125-1133; DOI: https://doi.org/10.1124/dmd.31.9.1125

D

  1. Dai, Renke

    1. CONCURRENT INDUCTION AND MECHANISM-BASED INACTIVATION OF CYP3A4 BY AN l-VALINAMIDE DERIVATIVE
      Gang Luo, Jianrong Lin, William D. Fiske, Renke Dai, Tian J. Yang, Sean Kim, Michael Sinz, Edward LeCluyse, Eric Solon, James M. Brennan, Irma H. Benedek, Summer Jolley, Darryl Gilbert, Lifei Wang, Frank W. Lee and Liang-Shang Gan
      Drug Metabolism and Disposition September 2003, 31 (9) 1170-1175; DOI: https://doi.org/10.1124/dmd.31.9.1170

  2. Ding, Xinxin

    1. SINGLE NUCLEOTIDE POLYMORPHISMS OF THE HUMAN CYP2A13 GENE: EVIDENCE FOR A NULL ALLELE
      Xiuling Zhang, Ying Chen, Yiqin Liu, Xiang Ren, Qing-Yu Zhang, Michele Caggana and Xinxin Ding
      Drug Metabolism and Disposition September 2003, 31 (9) 1081-1085; DOI: https://doi.org/10.1124/dmd.31.9.1081

  3. Duan, Su X.

    1. EVALUATION OF 3′-AZIDO-3′-DEOXYTHYMIDINE, MORPHINE, AND CODEINE AS PROBE SUBSTRATES FOR UDP-GLUCURONOSYLTRANSFERASE 2B7 (UGT2B7) IN HUMAN LIVER MICROSOMES: SPECIFICITY AND INFLUENCE OF THE UGT2B7*2 POLYMORPHISM
      Michael H. Court, Soundarajan Krishnaswamy, Qin Hao, Su X. Duan, Christopher J. Patten, Lisa L. von Moltke and David J. Greenblatt
      Drug Metabolism and Disposition September 2003, 31 (9) 1125-1133; DOI: https://doi.org/10.1124/dmd.31.9.1125

E

  1. Edwards, Robert J.

    1. COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS
      Jarmo S. Salonen, Leena Nyman, Alan R. Boobis, Robert J. Edwards, Patricia Watts, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria-José Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Andre Guillouzo, Laurent Corcos, Peter S. Goldfarb, David F.V. Lewis, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition September 2003, 31 (9) 1093-1102; DOI: https://doi.org/10.1124/dmd.31.9.1093

  2. Ekins, Sean

    1. GENERATION AND VALIDATION OF RAPID COMPUTATIONAL FILTERS FOR CYP2D6 AND CYP3A4
      Sean Ekins, Jennifer Berbaum and Richard K. Harrison
      Drug Metabolism and Disposition September 2003, 31 (9) 1077-1080; DOI: https://doi.org/10.1124/dmd.31.9.1077

  3. Ethell, Brian T.

    1. CONJUGATION OF CATECHOLS BY RECOMBINANT HUMAN SULFOTRANSFERASES, UDP-GLUCURONOSYLTRANSFERASES, AND SOLUBLE CATECHOL O-METHYLTRANSFERASE: STRUCTURE-CONJUGATION RELATIONSHIPS AND PREDICTIVE MODELS
      Jyrki Taskinen, Brian T. Ethell, Pia Pihlavisto, Alan M. Hood, Brian Burchell and Michael W. H. Coughtrie
      Drug Metabolism and Disposition September 2003, 31 (9) 1187-1197; DOI: https://doi.org/10.1124/dmd.31.9.1187

F

  1. Finel, Moshe

    1. GLUCURONIDATION OF ANABOLIC ANDROGENIC STEROIDS BY RECOMBINANT HUMAN UDP-GLUCURONOSYLTRANSFERASES
      Tiia Kuuranne, Mika Kurkela, Mario Thevis, Wilhelm Schänzer, Moshe Finel and Risto Kostiainen
      Drug Metabolism and Disposition September 2003, 31 (9) 1117-1124; DOI: https://doi.org/10.1124/dmd.31.9.1117

  2. Fiske, William D.

    1. CONCURRENT INDUCTION AND MECHANISM-BASED INACTIVATION OF CYP3A4 BY AN l-VALINAMIDE DERIVATIVE
      Gang Luo, Jianrong Lin, William D. Fiske, Renke Dai, Tian J. Yang, Sean Kim, Michael Sinz, Edward LeCluyse, Eric Solon, James M. Brennan, Irma H. Benedek, Summer Jolley, Darryl Gilbert, Lifei Wang, Frank W. Lee and Liang-Shang Gan
      Drug Metabolism and Disposition September 2003, 31 (9) 1170-1175; DOI: https://doi.org/10.1124/dmd.31.9.1170

G

  1. Galetin, Aleksandra

    1. ISOFORM SELECTIVITY AND KINETICS OF MORPHINE 3- AND 6-GLUCURONIDATION BY HUMAN UDP-GLUCURONOSYLTRANSFERASES: EVIDENCE FOR ATYPICAL GLUCURONIDATION KINETICS BY UGT2B7
      Andrew N. Stone, Peter I. Mackenzie, Aleksandra Galetin, J. Brian Houston and John O. Miners
      Drug Metabolism and Disposition September 2003, 31 (9) 1086-1089; DOI: https://doi.org/10.1124/dmd.31.9.1086
    2. MULTISITE KINETIC ANALYSIS OF INTERACTIONS BETWEEN PROTOTYPICAL CYP3A4 SUBGROUP SUBSTRATES: MIDAZOLAM, TESTOSTERONE, AND NIFEDIPINE
      Aleksandra Galetin, Stephen E. Clarke and J. Brian Houston
      Drug Metabolism and Disposition September 2003, 31 (9) 1108-1116; DOI: https://doi.org/10.1124/dmd.31.9.1108

  2. Gan, Liang-Shang

    1. CONCURRENT INDUCTION AND MECHANISM-BASED INACTIVATION OF CYP3A4 BY AN l-VALINAMIDE DERIVATIVE
      Gang Luo, Jianrong Lin, William D. Fiske, Renke Dai, Tian J. Yang, Sean Kim, Michael Sinz, Edward LeCluyse, Eric Solon, James M. Brennan, Irma H. Benedek, Summer Jolley, Darryl Gilbert, Lifei Wang, Frank W. Lee and Liang-Shang Gan
      Drug Metabolism and Disposition September 2003, 31 (9) 1170-1175; DOI: https://doi.org/10.1124/dmd.31.9.1170

  3. Gilbert, Darryl

    1. CONCURRENT INDUCTION AND MECHANISM-BASED INACTIVATION OF CYP3A4 BY AN l-VALINAMIDE DERIVATIVE
      Gang Luo, Jianrong Lin, William D. Fiske, Renke Dai, Tian J. Yang, Sean Kim, Michael Sinz, Edward LeCluyse, Eric Solon, James M. Brennan, Irma H. Benedek, Summer Jolley, Darryl Gilbert, Lifei Wang, Frank W. Lee and Liang-Shang Gan
      Drug Metabolism and Disposition September 2003, 31 (9) 1170-1175; DOI: https://doi.org/10.1124/dmd.31.9.1170

  4. Gillespie, T. A.

    1. METABOLISM, EXCRETION, AND PHARMACOKINETICS OF DULOXETINE IN HEALTHY HUMAN SUBJECTS
      R. J. Lantz, T. A. Gillespie, T. J. Rash, F. Kuo, M. Skinner, H-Y. Kuan and M. P. Knadler
      Drug Metabolism and Disposition September 2003, 31 (9) 1142-1150; DOI: https://doi.org/10.1124/dmd.31.9.1142

  5. Goldfarb, Peter S.

    1. COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS
      Jarmo S. Salonen, Leena Nyman, Alan R. Boobis, Robert J. Edwards, Patricia Watts, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria-José Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Andre Guillouzo, Laurent Corcos, Peter S. Goldfarb, David F.V. Lewis, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition September 2003, 31 (9) 1093-1102; DOI: https://doi.org/10.1124/dmd.31.9.1093

  6. Gómez-Lechón, Maria-José

    1. COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS
      Jarmo S. Salonen, Leena Nyman, Alan R. Boobis, Robert J. Edwards, Patricia Watts, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria-José Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Andre Guillouzo, Laurent Corcos, Peter S. Goldfarb, David F.V. Lewis, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition September 2003, 31 (9) 1093-1102; DOI: https://doi.org/10.1124/dmd.31.9.1093

  7. Greenblatt, David J.

    1. EVALUATION OF 3′-AZIDO-3′-DEOXYTHYMIDINE, MORPHINE, AND CODEINE AS PROBE SUBSTRATES FOR UDP-GLUCURONOSYLTRANSFERASE 2B7 (UGT2B7) IN HUMAN LIVER MICROSOMES: SPECIFICITY AND INFLUENCE OF THE UGT2B7*2 POLYMORPHISM
      Michael H. Court, Soundarajan Krishnaswamy, Qin Hao, Su X. Duan, Christopher J. Patten, Lisa L. von Moltke and David J. Greenblatt
      Drug Metabolism and Disposition September 2003, 31 (9) 1125-1133; DOI: https://doi.org/10.1124/dmd.31.9.1125

  8. Guillouzo, Andre

    1. COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS
      Jarmo S. Salonen, Leena Nyman, Alan R. Boobis, Robert J. Edwards, Patricia Watts, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria-José Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Andre Guillouzo, Laurent Corcos, Peter S. Goldfarb, David F.V. Lewis, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition September 2003, 31 (9) 1093-1102; DOI: https://doi.org/10.1124/dmd.31.9.1093

H

  1. Hao, Qin

    1. EVALUATION OF 3′-AZIDO-3′-DEOXYTHYMIDINE, MORPHINE, AND CODEINE AS PROBE SUBSTRATES FOR UDP-GLUCURONOSYLTRANSFERASE 2B7 (UGT2B7) IN HUMAN LIVER MICROSOMES: SPECIFICITY AND INFLUENCE OF THE UGT2B7*2 POLYMORPHISM
      Michael H. Court, Soundarajan Krishnaswamy, Qin Hao, Su X. Duan, Christopher J. Patten, Lisa L. von Moltke and David J. Greenblatt
      Drug Metabolism and Disposition September 2003, 31 (9) 1125-1133; DOI: https://doi.org/10.1124/dmd.31.9.1125

  2. Harrison, Richard K.

    1. GENERATION AND VALIDATION OF RAPID COMPUTATIONAL FILTERS FOR CYP2D6 AND CYP3A4
      Sean Ekins, Jennifer Berbaum and Richard K. Harrison
      Drug Metabolism and Disposition September 2003, 31 (9) 1077-1080; DOI: https://doi.org/10.1124/dmd.31.9.1077

  3. Hidestrand, Mats

    1. COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS
      Jarmo S. Salonen, Leena Nyman, Alan R. Boobis, Robert J. Edwards, Patricia Watts, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria-José Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Andre Guillouzo, Laurent Corcos, Peter S. Goldfarb, David F.V. Lewis, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition September 2003, 31 (9) 1093-1102; DOI: https://doi.org/10.1124/dmd.31.9.1093

  4. Hines, Ronald N.

    1. PUBLICATION OF STAND-ALONE SINGLE NUCLEOTIDE POLYMORPHISM (SNP) DISCOVERY DATA
      Ronald N. Hines
      Drug Metabolism and Disposition September 2003, 31 (9) 1073; DOI: https://doi.org/10.1124/dmd.31.9.1073

  5. Ho, Rodney J. Y.

    1. ONLY TRUNCATED, NOT COMPLETE CYTOCHROME P450 2D6 RNA TRANSCRIPT AND NO DETECTABLE ENZYME ACTIVITY ARE EXPRESSED IN HUMAN LYMPHOCYTES
      Lisa A. McConnachie, Brian Phillips, Manoj Bajpai, Danny D. Shen and Rodney J. Y. Ho
      Drug Metabolism and Disposition September 2003, 31 (9) 1103-1107; DOI: https://doi.org/10.1124/dmd.31.9.1103

  6. Hood, Alan M.

    1. CONJUGATION OF CATECHOLS BY RECOMBINANT HUMAN SULFOTRANSFERASES, UDP-GLUCURONOSYLTRANSFERASES, AND SOLUBLE CATECHOL O-METHYLTRANSFERASE: STRUCTURE-CONJUGATION RELATIONSHIPS AND PREDICTIVE MODELS
      Jyrki Taskinen, Brian T. Ethell, Pia Pihlavisto, Alan M. Hood, Brian Burchell and Michael W. H. Coughtrie
      Drug Metabolism and Disposition September 2003, 31 (9) 1187-1197; DOI: https://doi.org/10.1124/dmd.31.9.1187

  7. Houston, J. Brian

    1. ISOFORM SELECTIVITY AND KINETICS OF MORPHINE 3- AND 6-GLUCURONIDATION BY HUMAN UDP-GLUCURONOSYLTRANSFERASES: EVIDENCE FOR ATYPICAL GLUCURONIDATION KINETICS BY UGT2B7
      Andrew N. Stone, Peter I. Mackenzie, Aleksandra Galetin, J. Brian Houston and John O. Miners
      Drug Metabolism and Disposition September 2003, 31 (9) 1086-1089; DOI: https://doi.org/10.1124/dmd.31.9.1086
    2. MULTISITE KINETIC ANALYSIS OF INTERACTIONS BETWEEN PROTOTYPICAL CYP3A4 SUBGROUP SUBSTRATES: MIDAZOLAM, TESTOSTERONE, AND NIFEDIPINE
      Aleksandra Galetin, Stephen E. Clarke and J. Brian Houston
      Drug Metabolism and Disposition September 2003, 31 (9) 1108-1116; DOI: https://doi.org/10.1124/dmd.31.9.1108

I

  1. Ingelman-Sundberg, Magnus

    1. COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS
      Jarmo S. Salonen, Leena Nyman, Alan R. Boobis, Robert J. Edwards, Patricia Watts, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria-José Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Andre Guillouzo, Laurent Corcos, Peter S. Goldfarb, David F.V. Lewis, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition September 2003, 31 (9) 1093-1102; DOI: https://doi.org/10.1124/dmd.31.9.1093

J

  1. Johnson, Brendan M.

    1. APPLICATION OF COMPARTMENTAL MODELING TO AN EXAMINATION OF IN VITRO INTESTINAL PERMEABILITY DATA: ASSESSING THE IMPACT OF TISSUE UPTAKE, P-GLYCOPROTEIN, AND CYP3A
      Brendan M. Johnson, William N. Charman and Christopher J. H. Porter
      Drug Metabolism and Disposition September 2003, 31 (9) 1151-1160; DOI: https://doi.org/10.1124/dmd.31.9.1151

  2. Jolley, Summer

    1. CONCURRENT INDUCTION AND MECHANISM-BASED INACTIVATION OF CYP3A4 BY AN l-VALINAMIDE DERIVATIVE
      Gang Luo, Jianrong Lin, William D. Fiske, Renke Dai, Tian J. Yang, Sean Kim, Michael Sinz, Edward LeCluyse, Eric Solon, James M. Brennan, Irma H. Benedek, Summer Jolley, Darryl Gilbert, Lifei Wang, Frank W. Lee and Liang-Shang Gan
      Drug Metabolism and Disposition September 2003, 31 (9) 1170-1175; DOI: https://doi.org/10.1124/dmd.31.9.1170

K

  1. Kim, Kyoung-Ah

    1. INHIBITORY EFFECT OF GLYBURIDE ON HUMAN CYTOCHROME P450 ISOFORMS IN HUMAN LIVER MICROSOMES
      Kyoung-Ah Kim and Ji-Young Park
      Drug Metabolism and Disposition September 2003, 31 (9) 1090-1092; DOI: https://doi.org/10.1124/dmd.31.9.1090

  2. Kim, Sean

    1. CONCURRENT INDUCTION AND MECHANISM-BASED INACTIVATION OF CYP3A4 BY AN l-VALINAMIDE DERIVATIVE
      Gang Luo, Jianrong Lin, William D. Fiske, Renke Dai, Tian J. Yang, Sean Kim, Michael Sinz, Edward LeCluyse, Eric Solon, James M. Brennan, Irma H. Benedek, Summer Jolley, Darryl Gilbert, Lifei Wang, Frank W. Lee and Liang-Shang Gan
      Drug Metabolism and Disposition September 2003, 31 (9) 1170-1175; DOI: https://doi.org/10.1124/dmd.31.9.1170

  3. Klaassen, C. D.

    1. INDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 IN RAT LIVER IS ASSOCIATED WITH ALTERED VECTORIAL EXCRETION OF ACETAMINOPHEN METABOLITES
      A. L. Slitt, N. J. Cherrington, J. M. Maher and C. D. Klaassen
      Drug Metabolism and Disposition September 2003, 31 (9) 1176-1186; DOI: https://doi.org/10.1124/dmd.31.9.1176

  4. Knadler, M. P.

    1. METABOLISM, EXCRETION, AND PHARMACOKINETICS OF DULOXETINE IN HEALTHY HUMAN SUBJECTS
      R. J. Lantz, T. A. Gillespie, T. J. Rash, F. Kuo, M. Skinner, H-Y. Kuan and M. P. Knadler
      Drug Metabolism and Disposition September 2003, 31 (9) 1142-1150; DOI: https://doi.org/10.1124/dmd.31.9.1142

  5. Kostiainen, Risto

    1. GLUCURONIDATION OF ANABOLIC ANDROGENIC STEROIDS BY RECOMBINANT HUMAN UDP-GLUCURONOSYLTRANSFERASES
      Tiia Kuuranne, Mika Kurkela, Mario Thevis, Wilhelm Schänzer, Moshe Finel and Risto Kostiainen
      Drug Metabolism and Disposition September 2003, 31 (9) 1117-1124; DOI: https://doi.org/10.1124/dmd.31.9.1117

  6. Krishnaswamy, Soundarajan

    1. EVALUATION OF 3′-AZIDO-3′-DEOXYTHYMIDINE, MORPHINE, AND CODEINE AS PROBE SUBSTRATES FOR UDP-GLUCURONOSYLTRANSFERASE 2B7 (UGT2B7) IN HUMAN LIVER MICROSOMES: SPECIFICITY AND INFLUENCE OF THE UGT2B7*2 POLYMORPHISM
      Michael H. Court, Soundarajan Krishnaswamy, Qin Hao, Su X. Duan, Christopher J. Patten, Lisa L. von Moltke and David J. Greenblatt
      Drug Metabolism and Disposition September 2003, 31 (9) 1125-1133; DOI: https://doi.org/10.1124/dmd.31.9.1125

  7. Kuan, H-Y.

    1. METABOLISM, EXCRETION, AND PHARMACOKINETICS OF DULOXETINE IN HEALTHY HUMAN SUBJECTS
      R. J. Lantz, T. A. Gillespie, T. J. Rash, F. Kuo, M. Skinner, H-Y. Kuan and M. P. Knadler
      Drug Metabolism and Disposition September 2003, 31 (9) 1142-1150; DOI: https://doi.org/10.1124/dmd.31.9.1142

  8. Kuo, F.

    1. METABOLISM, EXCRETION, AND PHARMACOKINETICS OF DULOXETINE IN HEALTHY HUMAN SUBJECTS
      R. J. Lantz, T. A. Gillespie, T. J. Rash, F. Kuo, M. Skinner, H-Y. Kuan and M. P. Knadler
      Drug Metabolism and Disposition September 2003, 31 (9) 1142-1150; DOI: https://doi.org/10.1124/dmd.31.9.1142

  9. Kurkela, Mika

    1. GLUCURONIDATION OF ANABOLIC ANDROGENIC STEROIDS BY RECOMBINANT HUMAN UDP-GLUCURONOSYLTRANSFERASES
      Tiia Kuuranne, Mika Kurkela, Mario Thevis, Wilhelm Schänzer, Moshe Finel and Risto Kostiainen
      Drug Metabolism and Disposition September 2003, 31 (9) 1117-1124; DOI: https://doi.org/10.1124/dmd.31.9.1117

  10. Kuuranne, Tiia

    1. GLUCURONIDATION OF ANABOLIC ANDROGENIC STEROIDS BY RECOMBINANT HUMAN UDP-GLUCURONOSYLTRANSFERASES
      Tiia Kuuranne, Mika Kurkela, Mario Thevis, Wilhelm Schänzer, Moshe Finel and Risto Kostiainen
      Drug Metabolism and Disposition September 2003, 31 (9) 1117-1124; DOI: https://doi.org/10.1124/dmd.31.9.1117

L

  1. Lake, Brian G.

    1. COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS
      Jarmo S. Salonen, Leena Nyman, Alan R. Boobis, Robert J. Edwards, Patricia Watts, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria-José Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Andre Guillouzo, Laurent Corcos, Peter S. Goldfarb, David F.V. Lewis, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition September 2003, 31 (9) 1093-1102; DOI: https://doi.org/10.1124/dmd.31.9.1093

  2. Lantz, R. J.

    1. METABOLISM, EXCRETION, AND PHARMACOKINETICS OF DULOXETINE IN HEALTHY HUMAN SUBJECTS
      R. J. Lantz, T. A. Gillespie, T. J. Rash, F. Kuo, M. Skinner, H-Y. Kuan and M. P. Knadler
      Drug Metabolism and Disposition September 2003, 31 (9) 1142-1150; DOI: https://doi.org/10.1124/dmd.31.9.1142

  3. LeCluyse, Edward

    1. CONCURRENT INDUCTION AND MECHANISM-BASED INACTIVATION OF CYP3A4 BY AN l-VALINAMIDE DERIVATIVE
      Gang Luo, Jianrong Lin, William D. Fiske, Renke Dai, Tian J. Yang, Sean Kim, Michael Sinz, Edward LeCluyse, Eric Solon, James M. Brennan, Irma H. Benedek, Summer Jolley, Darryl Gilbert, Lifei Wang, Frank W. Lee and Liang-Shang Gan
      Drug Metabolism and Disposition September 2003, 31 (9) 1170-1175; DOI: https://doi.org/10.1124/dmd.31.9.1170

  4. Lee, Frank W.

    1. CONCURRENT INDUCTION AND MECHANISM-BASED INACTIVATION OF CYP3A4 BY AN l-VALINAMIDE DERIVATIVE
      Gang Luo, Jianrong Lin, William D. Fiske, Renke Dai, Tian J. Yang, Sean Kim, Michael Sinz, Edward LeCluyse, Eric Solon, James M. Brennan, Irma H. Benedek, Summer Jolley, Darryl Gilbert, Lifei Wang, Frank W. Lee and Liang-Shang Gan
      Drug Metabolism and Disposition September 2003, 31 (9) 1170-1175; DOI: https://doi.org/10.1124/dmd.31.9.1170

  5. Lewis, David F.V.

    1. COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS
      Jarmo S. Salonen, Leena Nyman, Alan R. Boobis, Robert J. Edwards, Patricia Watts, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria-José Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Andre Guillouzo, Laurent Corcos, Peter S. Goldfarb, David F.V. Lewis, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition September 2003, 31 (9) 1093-1102; DOI: https://doi.org/10.1124/dmd.31.9.1093

  6. Li, Yinghe

    1. SUBSTRATE SPECIFICITY AND KINETIC PROPERTIES OF SEVEN HETEROLOGOUSLY EXPRESSED DOG CYTOCHROMES P450
      Magang Shou, Ryan Norcross, Grit Sandig, Ping Lu, Yinghe Li, Yuh Lin, Qin Mei, A. David Rodrigues and Thomas H. Rushmore
      Drug Metabolism and Disposition September 2003, 31 (9) 1161-1169; DOI: https://doi.org/10.1124/dmd.31.9.1161

  7. Lin, Jianrong

    1. CONCURRENT INDUCTION AND MECHANISM-BASED INACTIVATION OF CYP3A4 BY AN l-VALINAMIDE DERIVATIVE
      Gang Luo, Jianrong Lin, William D. Fiske, Renke Dai, Tian J. Yang, Sean Kim, Michael Sinz, Edward LeCluyse, Eric Solon, James M. Brennan, Irma H. Benedek, Summer Jolley, Darryl Gilbert, Lifei Wang, Frank W. Lee and Liang-Shang Gan
      Drug Metabolism and Disposition September 2003, 31 (9) 1170-1175; DOI: https://doi.org/10.1124/dmd.31.9.1170

  8. Lin, Yuh

    1. SUBSTRATE SPECIFICITY AND KINETIC PROPERTIES OF SEVEN HETEROLOGOUSLY EXPRESSED DOG CYTOCHROMES P450
      Magang Shou, Ryan Norcross, Grit Sandig, Ping Lu, Yinghe Li, Yuh Lin, Qin Mei, A. David Rodrigues and Thomas H. Rushmore
      Drug Metabolism and Disposition September 2003, 31 (9) 1161-1169; DOI: https://doi.org/10.1124/dmd.31.9.1161

  9. Liu, Yiqin

    1. SINGLE NUCLEOTIDE POLYMORPHISMS OF THE HUMAN CYP2A13 GENE: EVIDENCE FOR A NULL ALLELE
      Xiuling Zhang, Ying Chen, Yiqin Liu, Xiang Ren, Qing-Yu Zhang, Michele Caggana and Xinxin Ding
      Drug Metabolism and Disposition September 2003, 31 (9) 1081-1085; DOI: https://doi.org/10.1124/dmd.31.9.1081

  10. Lu, Ping

    1. SUBSTRATE SPECIFICITY AND KINETIC PROPERTIES OF SEVEN HETEROLOGOUSLY EXPRESSED DOG CYTOCHROMES P450
      Magang Shou, Ryan Norcross, Grit Sandig, Ping Lu, Yinghe Li, Yuh Lin, Qin Mei, A. David Rodrigues and Thomas H. Rushmore
      Drug Metabolism and Disposition September 2003, 31 (9) 1161-1169; DOI: https://doi.org/10.1124/dmd.31.9.1161

  11. Luo, Gang

    1. CONCURRENT INDUCTION AND MECHANISM-BASED INACTIVATION OF CYP3A4 BY AN l-VALINAMIDE DERIVATIVE
      Gang Luo, Jianrong Lin, William D. Fiske, Renke Dai, Tian J. Yang, Sean Kim, Michael Sinz, Edward LeCluyse, Eric Solon, James M. Brennan, Irma H. Benedek, Summer Jolley, Darryl Gilbert, Lifei Wang, Frank W. Lee and Liang-Shang Gan
      Drug Metabolism and Disposition September 2003, 31 (9) 1170-1175; DOI: https://doi.org/10.1124/dmd.31.9.1170

M

  1. Mackenzie, Peter I.

    1. ISOFORM SELECTIVITY AND KINETICS OF MORPHINE 3- AND 6-GLUCURONIDATION BY HUMAN UDP-GLUCURONOSYLTRANSFERASES: EVIDENCE FOR ATYPICAL GLUCURONIDATION KINETICS BY UGT2B7
      Andrew N. Stone, Peter I. Mackenzie, Aleksandra Galetin, J. Brian Houston and John O. Miners
      Drug Metabolism and Disposition September 2003, 31 (9) 1086-1089; DOI: https://doi.org/10.1124/dmd.31.9.1086

  2. Maher, J. M.

    1. INDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 IN RAT LIVER IS ASSOCIATED WITH ALTERED VECTORIAL EXCRETION OF ACETAMINOPHEN METABOLITES
      A. L. Slitt, N. J. Cherrington, J. M. Maher and C. D. Klaassen
      Drug Metabolism and Disposition September 2003, 31 (9) 1176-1186; DOI: https://doi.org/10.1124/dmd.31.9.1176

  3. Massey, Thomas E.

    1. BIOTRANSFORMATION OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE (NNK) IN PERIPHERAL HUMAN LUNG MICROSOMES
      Graeme B. J. Smith, John R. Bend, Leanne L. Bedard, Ken R. Reid, Dimitri Petsikas and Thomas E. Massey
      Drug Metabolism and Disposition September 2003, 31 (9) 1134-1141; DOI: https://doi.org/10.1124/dmd.31.9.1134

  4. McConnachie, Lisa A.

    1. ONLY TRUNCATED, NOT COMPLETE CYTOCHROME P450 2D6 RNA TRANSCRIPT AND NO DETECTABLE ENZYME ACTIVITY ARE EXPRESSED IN HUMAN LYMPHOCYTES
      Lisa A. McConnachie, Brian Phillips, Manoj Bajpai, Danny D. Shen and Rodney J. Y. Ho
      Drug Metabolism and Disposition September 2003, 31 (9) 1103-1107; DOI: https://doi.org/10.1124/dmd.31.9.1103

  5. Mei, Qin

    1. SUBSTRATE SPECIFICITY AND KINETIC PROPERTIES OF SEVEN HETEROLOGOUSLY EXPRESSED DOG CYTOCHROMES P450
      Magang Shou, Ryan Norcross, Grit Sandig, Ping Lu, Yinghe Li, Yuh Lin, Qin Mei, A. David Rodrigues and Thomas H. Rushmore
      Drug Metabolism and Disposition September 2003, 31 (9) 1161-1169; DOI: https://doi.org/10.1124/dmd.31.9.1161

  6. Miners, John O.

    1. ISOFORM SELECTIVITY AND KINETICS OF MORPHINE 3- AND 6-GLUCURONIDATION BY HUMAN UDP-GLUCURONOSYLTRANSFERASES: EVIDENCE FOR ATYPICAL GLUCURONIDATION KINETICS BY UGT2B7
      Andrew N. Stone, Peter I. Mackenzie, Aleksandra Galetin, J. Brian Houston and John O. Miners
      Drug Metabolism and Disposition September 2003, 31 (9) 1086-1089; DOI: https://doi.org/10.1124/dmd.31.9.1086

N

  1. Norcross, Ryan

    1. SUBSTRATE SPECIFICITY AND KINETIC PROPERTIES OF SEVEN HETEROLOGOUSLY EXPRESSED DOG CYTOCHROMES P450
      Magang Shou, Ryan Norcross, Grit Sandig, Ping Lu, Yinghe Li, Yuh Lin, Qin Mei, A. David Rodrigues and Thomas H. Rushmore
      Drug Metabolism and Disposition September 2003, 31 (9) 1161-1169; DOI: https://doi.org/10.1124/dmd.31.9.1161

  2. Nyman, Leena

    1. COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS
      Jarmo S. Salonen, Leena Nyman, Alan R. Boobis, Robert J. Edwards, Patricia Watts, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria-José Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Andre Guillouzo, Laurent Corcos, Peter S. Goldfarb, David F.V. Lewis, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition September 2003, 31 (9) 1093-1102; DOI: https://doi.org/10.1124/dmd.31.9.1093

P

  1. Park, Ji-Young

    1. INHIBITORY EFFECT OF GLYBURIDE ON HUMAN CYTOCHROME P450 ISOFORMS IN HUMAN LIVER MICROSOMES
      Kyoung-Ah Kim and Ji-Young Park
      Drug Metabolism and Disposition September 2003, 31 (9) 1090-1092; DOI: https://doi.org/10.1124/dmd.31.9.1090

  2. Patten, Christopher J.

    1. EVALUATION OF 3′-AZIDO-3′-DEOXYTHYMIDINE, MORPHINE, AND CODEINE AS PROBE SUBSTRATES FOR UDP-GLUCURONOSYLTRANSFERASE 2B7 (UGT2B7) IN HUMAN LIVER MICROSOMES: SPECIFICITY AND INFLUENCE OF THE UGT2B7*2 POLYMORPHISM
      Michael H. Court, Soundarajan Krishnaswamy, Qin Hao, Su X. Duan, Christopher J. Patten, Lisa L. von Moltke and David J. Greenblatt
      Drug Metabolism and Disposition September 2003, 31 (9) 1125-1133; DOI: https://doi.org/10.1124/dmd.31.9.1125

  3. Pelkonen, Olavi

    1. COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS
      Jarmo S. Salonen, Leena Nyman, Alan R. Boobis, Robert J. Edwards, Patricia Watts, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria-José Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Andre Guillouzo, Laurent Corcos, Peter S. Goldfarb, David F.V. Lewis, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition September 2003, 31 (9) 1093-1102; DOI: https://doi.org/10.1124/dmd.31.9.1093

  4. Periandythevar, Parameswaran

    1. SPURIOUS OBSERVATION OF SPLENIC CYP2B1 EXPRESSION
      Meena R. Sharma, Parameswaran Periandythevar and Bernard H. Shapiro
      Drug Metabolism and Disposition September 2003, 31 (9) 1074-1076; DOI: https://doi.org/10.1124/dmd.31.9.1074

  5. Petsikas, Dimitri

    1. BIOTRANSFORMATION OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE (NNK) IN PERIPHERAL HUMAN LUNG MICROSOMES
      Graeme B. J. Smith, John R. Bend, Leanne L. Bedard, Ken R. Reid, Dimitri Petsikas and Thomas E. Massey
      Drug Metabolism and Disposition September 2003, 31 (9) 1134-1141; DOI: https://doi.org/10.1124/dmd.31.9.1134

  6. Phillips, Brian

    1. ONLY TRUNCATED, NOT COMPLETE CYTOCHROME P450 2D6 RNA TRANSCRIPT AND NO DETECTABLE ENZYME ACTIVITY ARE EXPRESSED IN HUMAN LYMPHOCYTES
      Lisa A. McConnachie, Brian Phillips, Manoj Bajpai, Danny D. Shen and Rodney J. Y. Ho
      Drug Metabolism and Disposition September 2003, 31 (9) 1103-1107; DOI: https://doi.org/10.1124/dmd.31.9.1103

  7. Pihlavisto, Pia

    1. CONJUGATION OF CATECHOLS BY RECOMBINANT HUMAN SULFOTRANSFERASES, UDP-GLUCURONOSYLTRANSFERASES, AND SOLUBLE CATECHOL O-METHYLTRANSFERASE: STRUCTURE-CONJUGATION RELATIONSHIPS AND PREDICTIVE MODELS
      Jyrki Taskinen, Brian T. Ethell, Pia Pihlavisto, Alan M. Hood, Brian Burchell and Michael W. H. Coughtrie
      Drug Metabolism and Disposition September 2003, 31 (9) 1187-1197; DOI: https://doi.org/10.1124/dmd.31.9.1187

  8. Porter, Christopher J. H.

    1. APPLICATION OF COMPARTMENTAL MODELING TO AN EXAMINATION OF IN VITRO INTESTINAL PERMEABILITY DATA: ASSESSING THE IMPACT OF TISSUE UPTAKE, P-GLYCOPROTEIN, AND CYP3A
      Brendan M. Johnson, William N. Charman and Christopher J. H. Porter
      Drug Metabolism and Disposition September 2003, 31 (9) 1151-1160; DOI: https://doi.org/10.1124/dmd.31.9.1151

  9. Price, Roger J.

    1. COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS
      Jarmo S. Salonen, Leena Nyman, Alan R. Boobis, Robert J. Edwards, Patricia Watts, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria-José Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Andre Guillouzo, Laurent Corcos, Peter S. Goldfarb, David F.V. Lewis, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition September 2003, 31 (9) 1093-1102; DOI: https://doi.org/10.1124/dmd.31.9.1093

R

  1. Rash, T. J.

    1. METABOLISM, EXCRETION, AND PHARMACOKINETICS OF DULOXETINE IN HEALTHY HUMAN SUBJECTS
      R. J. Lantz, T. A. Gillespie, T. J. Rash, F. Kuo, M. Skinner, H-Y. Kuan and M. P. Knadler
      Drug Metabolism and Disposition September 2003, 31 (9) 1142-1150; DOI: https://doi.org/10.1124/dmd.31.9.1142

  2. Reid, Ken R.

    1. BIOTRANSFORMATION OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE (NNK) IN PERIPHERAL HUMAN LUNG MICROSOMES
      Graeme B. J. Smith, John R. Bend, Leanne L. Bedard, Ken R. Reid, Dimitri Petsikas and Thomas E. Massey
      Drug Metabolism and Disposition September 2003, 31 (9) 1134-1141; DOI: https://doi.org/10.1124/dmd.31.9.1134

  3. Ren, Xiang

    1. SINGLE NUCLEOTIDE POLYMORPHISMS OF THE HUMAN CYP2A13 GENE: EVIDENCE FOR A NULL ALLELE
      Xiuling Zhang, Ying Chen, Yiqin Liu, Xiang Ren, Qing-Yu Zhang, Michele Caggana and Xinxin Ding
      Drug Metabolism and Disposition September 2003, 31 (9) 1081-1085; DOI: https://doi.org/10.1124/dmd.31.9.1081

  4. Renwick, Anthony B.

    1. COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS
      Jarmo S. Salonen, Leena Nyman, Alan R. Boobis, Robert J. Edwards, Patricia Watts, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria-José Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Andre Guillouzo, Laurent Corcos, Peter S. Goldfarb, David F.V. Lewis, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition September 2003, 31 (9) 1093-1102; DOI: https://doi.org/10.1124/dmd.31.9.1093

  5. Rodrigues, A. David

    1. SUBSTRATE SPECIFICITY AND KINETIC PROPERTIES OF SEVEN HETEROLOGOUSLY EXPRESSED DOG CYTOCHROMES P450
      Magang Shou, Ryan Norcross, Grit Sandig, Ping Lu, Yinghe Li, Yuh Lin, Qin Mei, A. David Rodrigues and Thomas H. Rushmore
      Drug Metabolism and Disposition September 2003, 31 (9) 1161-1169; DOI: https://doi.org/10.1124/dmd.31.9.1161

  6. Rushmore, Thomas H.

    1. SUBSTRATE SPECIFICITY AND KINETIC PROPERTIES OF SEVEN HETEROLOGOUSLY EXPRESSED DOG CYTOCHROMES P450
      Magang Shou, Ryan Norcross, Grit Sandig, Ping Lu, Yinghe Li, Yuh Lin, Qin Mei, A. David Rodrigues and Thomas H. Rushmore
      Drug Metabolism and Disposition September 2003, 31 (9) 1161-1169; DOI: https://doi.org/10.1124/dmd.31.9.1161

S

  1. Salonen, Jarmo S.

    1. COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS
      Jarmo S. Salonen, Leena Nyman, Alan R. Boobis, Robert J. Edwards, Patricia Watts, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria-José Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Andre Guillouzo, Laurent Corcos, Peter S. Goldfarb, David F.V. Lewis, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition September 2003, 31 (9) 1093-1102; DOI: https://doi.org/10.1124/dmd.31.9.1093

  2. Sandig, Grit

    1. SUBSTRATE SPECIFICITY AND KINETIC PROPERTIES OF SEVEN HETEROLOGOUSLY EXPRESSED DOG CYTOCHROMES P450
      Magang Shou, Ryan Norcross, Grit Sandig, Ping Lu, Yinghe Li, Yuh Lin, Qin Mei, A. David Rodrigues and Thomas H. Rushmore
      Drug Metabolism and Disposition September 2003, 31 (9) 1161-1169; DOI: https://doi.org/10.1124/dmd.31.9.1161

  3. Schänzer, Wilhelm

    1. GLUCURONIDATION OF ANABOLIC ANDROGENIC STEROIDS BY RECOMBINANT HUMAN UDP-GLUCURONOSYLTRANSFERASES
      Tiia Kuuranne, Mika Kurkela, Mario Thevis, Wilhelm Schänzer, Moshe Finel and Risto Kostiainen
      Drug Metabolism and Disposition September 2003, 31 (9) 1117-1124; DOI: https://doi.org/10.1124/dmd.31.9.1117

  4. Shapiro, Bernard H.

    1. SPURIOUS OBSERVATION OF SPLENIC CYP2B1 EXPRESSION
      Meena R. Sharma, Parameswaran Periandythevar and Bernard H. Shapiro
      Drug Metabolism and Disposition September 2003, 31 (9) 1074-1076; DOI: https://doi.org/10.1124/dmd.31.9.1074

  5. Sharma, Meena R.

    1. SPURIOUS OBSERVATION OF SPLENIC CYP2B1 EXPRESSION
      Meena R. Sharma, Parameswaran Periandythevar and Bernard H. Shapiro
      Drug Metabolism and Disposition September 2003, 31 (9) 1074-1076; DOI: https://doi.org/10.1124/dmd.31.9.1074

  6. Shen, Danny D.

    1. ONLY TRUNCATED, NOT COMPLETE CYTOCHROME P450 2D6 RNA TRANSCRIPT AND NO DETECTABLE ENZYME ACTIVITY ARE EXPRESSED IN HUMAN LYMPHOCYTES
      Lisa A. McConnachie, Brian Phillips, Manoj Bajpai, Danny D. Shen and Rodney J. Y. Ho
      Drug Metabolism and Disposition September 2003, 31 (9) 1103-1107; DOI: https://doi.org/10.1124/dmd.31.9.1103

  7. Shou, Magang

    1. SUBSTRATE SPECIFICITY AND KINETIC PROPERTIES OF SEVEN HETEROLOGOUSLY EXPRESSED DOG CYTOCHROMES P450
      Magang Shou, Ryan Norcross, Grit Sandig, Ping Lu, Yinghe Li, Yuh Lin, Qin Mei, A. David Rodrigues and Thomas H. Rushmore
      Drug Metabolism and Disposition September 2003, 31 (9) 1161-1169; DOI: https://doi.org/10.1124/dmd.31.9.1161

  8. Sinz, Michael

    1. CONCURRENT INDUCTION AND MECHANISM-BASED INACTIVATION OF CYP3A4 BY AN l-VALINAMIDE DERIVATIVE
      Gang Luo, Jianrong Lin, William D. Fiske, Renke Dai, Tian J. Yang, Sean Kim, Michael Sinz, Edward LeCluyse, Eric Solon, James M. Brennan, Irma H. Benedek, Summer Jolley, Darryl Gilbert, Lifei Wang, Frank W. Lee and Liang-Shang Gan
      Drug Metabolism and Disposition September 2003, 31 (9) 1170-1175; DOI: https://doi.org/10.1124/dmd.31.9.1170

  9. Skinner, M.

    1. METABOLISM, EXCRETION, AND PHARMACOKINETICS OF DULOXETINE IN HEALTHY HUMAN SUBJECTS
      R. J. Lantz, T. A. Gillespie, T. J. Rash, F. Kuo, M. Skinner, H-Y. Kuan and M. P. Knadler
      Drug Metabolism and Disposition September 2003, 31 (9) 1142-1150; DOI: https://doi.org/10.1124/dmd.31.9.1142

  10. Slitt, A. L.

    1. INDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 IN RAT LIVER IS ASSOCIATED WITH ALTERED VECTORIAL EXCRETION OF ACETAMINOPHEN METABOLITES
      A. L. Slitt, N. J. Cherrington, J. M. Maher and C. D. Klaassen
      Drug Metabolism and Disposition September 2003, 31 (9) 1176-1186; DOI: https://doi.org/10.1124/dmd.31.9.1176

  11. Smith, Graeme B. J.

    1. BIOTRANSFORMATION OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE (NNK) IN PERIPHERAL HUMAN LUNG MICROSOMES
      Graeme B. J. Smith, John R. Bend, Leanne L. Bedard, Ken R. Reid, Dimitri Petsikas and Thomas E. Massey
      Drug Metabolism and Disposition September 2003, 31 (9) 1134-1141; DOI: https://doi.org/10.1124/dmd.31.9.1134

  12. Solon, Eric

    1. CONCURRENT INDUCTION AND MECHANISM-BASED INACTIVATION OF CYP3A4 BY AN l-VALINAMIDE DERIVATIVE
      Gang Luo, Jianrong Lin, William D. Fiske, Renke Dai, Tian J. Yang, Sean Kim, Michael Sinz, Edward LeCluyse, Eric Solon, James M. Brennan, Irma H. Benedek, Summer Jolley, Darryl Gilbert, Lifei Wang, Frank W. Lee and Liang-Shang Gan
      Drug Metabolism and Disposition September 2003, 31 (9) 1170-1175; DOI: https://doi.org/10.1124/dmd.31.9.1170

  13. Stone, Andrew N.

    1. ISOFORM SELECTIVITY AND KINETICS OF MORPHINE 3- AND 6-GLUCURONIDATION BY HUMAN UDP-GLUCURONOSYLTRANSFERASES: EVIDENCE FOR ATYPICAL GLUCURONIDATION KINETICS BY UGT2B7
      Andrew N. Stone, Peter I. Mackenzie, Aleksandra Galetin, J. Brian Houston and John O. Miners
      Drug Metabolism and Disposition September 2003, 31 (9) 1086-1089; DOI: https://doi.org/10.1124/dmd.31.9.1086

T

  1. Taavitsainen, Päivi

    1. COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS
      Jarmo S. Salonen, Leena Nyman, Alan R. Boobis, Robert J. Edwards, Patricia Watts, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria-José Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Andre Guillouzo, Laurent Corcos, Peter S. Goldfarb, David F.V. Lewis, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition September 2003, 31 (9) 1093-1102; DOI: https://doi.org/10.1124/dmd.31.9.1093

  2. Taskinen, Jyrki

    1. CONJUGATION OF CATECHOLS BY RECOMBINANT HUMAN SULFOTRANSFERASES, UDP-GLUCURONOSYLTRANSFERASES, AND SOLUBLE CATECHOL O-METHYLTRANSFERASE: STRUCTURE-CONJUGATION RELATIONSHIPS AND PREDICTIVE MODELS
      Jyrki Taskinen, Brian T. Ethell, Pia Pihlavisto, Alan M. Hood, Brian Burchell and Michael W. H. Coughtrie
      Drug Metabolism and Disposition September 2003, 31 (9) 1187-1197; DOI: https://doi.org/10.1124/dmd.31.9.1187

  3. Thevis, Mario

    1. GLUCURONIDATION OF ANABOLIC ANDROGENIC STEROIDS BY RECOMBINANT HUMAN UDP-GLUCURONOSYLTRANSFERASES
      Tiia Kuuranne, Mika Kurkela, Mario Thevis, Wilhelm Schänzer, Moshe Finel and Risto Kostiainen
      Drug Metabolism and Disposition September 2003, 31 (9) 1117-1124; DOI: https://doi.org/10.1124/dmd.31.9.1117

V

  1. von Moltke, Lisa L.

    1. EVALUATION OF 3′-AZIDO-3′-DEOXYTHYMIDINE, MORPHINE, AND CODEINE AS PROBE SUBSTRATES FOR UDP-GLUCURONOSYLTRANSFERASE 2B7 (UGT2B7) IN HUMAN LIVER MICROSOMES: SPECIFICITY AND INFLUENCE OF THE UGT2B7*2 POLYMORPHISM
      Michael H. Court, Soundarajan Krishnaswamy, Qin Hao, Su X. Duan, Christopher J. Patten, Lisa L. von Moltke and David J. Greenblatt
      Drug Metabolism and Disposition September 2003, 31 (9) 1125-1133; DOI: https://doi.org/10.1124/dmd.31.9.1125

W

  1. Wang, Lifei

    1. CONCURRENT INDUCTION AND MECHANISM-BASED INACTIVATION OF CYP3A4 BY AN l-VALINAMIDE DERIVATIVE
      Gang Luo, Jianrong Lin, William D. Fiske, Renke Dai, Tian J. Yang, Sean Kim, Michael Sinz, Edward LeCluyse, Eric Solon, James M. Brennan, Irma H. Benedek, Summer Jolley, Darryl Gilbert, Lifei Wang, Frank W. Lee and Liang-Shang Gan
      Drug Metabolism and Disposition September 2003, 31 (9) 1170-1175; DOI: https://doi.org/10.1124/dmd.31.9.1170

  2. Watts, Patricia

    1. COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS
      Jarmo S. Salonen, Leena Nyman, Alan R. Boobis, Robert J. Edwards, Patricia Watts, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria-José Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Andre Guillouzo, Laurent Corcos, Peter S. Goldfarb, David F.V. Lewis, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition September 2003, 31 (9) 1093-1102; DOI: https://doi.org/10.1124/dmd.31.9.1093

Y

  1. Yang, Tian J.

    1. CONCURRENT INDUCTION AND MECHANISM-BASED INACTIVATION OF CYP3A4 BY AN l-VALINAMIDE DERIVATIVE
      Gang Luo, Jianrong Lin, William D. Fiske, Renke Dai, Tian J. Yang, Sean Kim, Michael Sinz, Edward LeCluyse, Eric Solon, James M. Brennan, Irma H. Benedek, Summer Jolley, Darryl Gilbert, Lifei Wang, Frank W. Lee and Liang-Shang Gan
      Drug Metabolism and Disposition September 2003, 31 (9) 1170-1175; DOI: https://doi.org/10.1124/dmd.31.9.1170

Z

  1. Zhang, Qing-Yu

    1. SINGLE NUCLEOTIDE POLYMORPHISMS OF THE HUMAN CYP2A13 GENE: EVIDENCE FOR A NULL ALLELE
      Xiuling Zhang, Ying Chen, Yiqin Liu, Xiang Ren, Qing-Yu Zhang, Michele Caggana and Xinxin Ding
      Drug Metabolism and Disposition September 2003, 31 (9) 1081-1085; DOI: https://doi.org/10.1124/dmd.31.9.1081

  2. Zhang, Xiuling

    1. SINGLE NUCLEOTIDE POLYMORPHISMS OF THE HUMAN CYP2A13 GENE: EVIDENCE FOR A NULL ALLELE
      Xiuling Zhang, Ying Chen, Yiqin Liu, Xiang Ren, Qing-Yu Zhang, Michele Caggana and Xinxin Ding
      Drug Metabolism and Disposition September 2003, 31 (9) 1081-1085; DOI: https://doi.org/10.1124/dmd.31.9.1081
Back to top

In this issue